Search results
Appearance
Page title matches
- = PROBE FOR UNIVERSAL DETECTION OF CIRCULATING TUMOR CELLS = ...iu Zhang of Houston TX US|Shaun Xiaoliu Zhang]], [[:Category:Xinping Fu of Houston TX US|Xinping Fu]] ...1 KB (186 words) - 10:44, 25 May 2025
- = TREATMENT AND PREVENTION OF CONDITIONS ASSOCIATED WITH RESPIRATORY DISEASES = ...gens attached to, integrated into, or associated with a liposomal membrane of the liposome. ...2 KB (271 words) - 07:53, 23 June 2025
Page text matches
- = PROBE FOR UNIVERSAL DETECTION OF CIRCULATING TUMOR CELLS = ...iu Zhang of Houston TX US|Shaun Xiaoliu Zhang]], [[:Category:Xinping Fu of Houston TX US|Xinping Fu]] ...1 KB (186 words) - 10:44, 25 May 2025
- = TREATMENT AND PREVENTION OF CONDITIONS ASSOCIATED WITH RESPIRATORY DISEASES = ...gens attached to, integrated into, or associated with a liposomal membrane of the liposome. ...2 KB (271 words) - 07:53, 23 June 2025
- ..., THE UNIVERSITY OF TEXAS SYSTEM|BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM]] [[Category:BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM]] ...1 KB (162 words) - 07:33, 31 March 2025
- =ANTI-CD94 ANTIBODY AND CHIMERIC ANTIGEN RECEPTOR AND METHODS OF USE THEREOF= ..., THE UNIVERSITY OF TEXAS SYSTEM|BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM]] ...1 KB (205 words) - 07:33, 31 March 2025
- = COMPOSITIONS FOR STIMULATION OF MAMMALIAN INNATE IMMUNE RESISTANCE TO PATHOGENS = ...uch an infection, comprising the step of administering an effective amount of a stir composition to the individual. ...2 KB (289 words) - 01:52, 23 May 2025
- = COMPOSITIONS FOR STIMULATION OF MAMMALIAN INNATE IMMUNE RESISTANCE TO PATHOGENS = ...uch an infection, comprising the step of administering an effective amount of a stir composition to the individual. ...2 KB (301 words) - 03:09, 23 May 2025
- = ANTI-CD19 AND ANTI-CD79B CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE THEREOF = ...rising both anti-cd19 and anti-cd79b cars and methods for use in treatment of b-cell malignancies. also disclosed are polynucleotides encoding an anti-cd ...3 KB (354 words) - 08:56, 25 May 2025
- ..., THE UNIVERSITY OF TEXAS SYSTEM|BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM]] [[Category:BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM]] ...2 KB (327 words) - 07:33, 31 March 2025
- = INHIBITORS OF RECEPTOR INTERACTING PROTEIN KINASE I FOR THE TREATMENT OF DISEASE = ...which inhibit ripk1, pharmaceutical compositions, and methods of treatment of ripk1-mediated diseases, such as neurodegenerative disorders, inflammatory ...3 KB (343 words) - 18:27, 3 July 2025
- = ANTI-TROP2 ANTIBODY COMBINATION THERAPIES AND METHODS OF USE THEREOF = ...ous aspects of this disclosure, the present disclosure relates to a method of treating cancer in a subject in need thereof comprising administering to th ...2 KB (286 words) - 01:52, 23 May 2025
- Number of patent applications containing 'Wellness Technologies' or its variations: 1 ...SITY (20250037884). CYBER-PHYSICAL SYSTEM TO ENHANCE USABILITY AND QUALITY OF TELEHEALTH CONSULTATION]] ...856 bytes (111 words) - 09:06, 19 February 2025
- = ANTI-TROP2 ANTIBODY COMBINATION THERAPIES AND METHODS OF USE THEREOF = ...ous aspects of this disclosure, the present disclosure relates to a method of treating cancer in a subject in need thereof comprising administering to th ...2 KB (298 words) - 03:10, 23 May 2025
- ...:{"@type":"Organization","name":"BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM"},"additionalProperty":[{"@type":"PropertyValue","name":"IPC Classification =DUAL SPECIFICITY ANTIBODIES TO PD-L1 AND PD-L2 AND METHODS OF USE THEREFOR= ...4 KB (539 words) - 14:38, 28 April 2025
- ...:{"@type":"Organization","name":"BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM"},"additionalProperty":[{"@type":"PropertyValue","name":"IPC Classification ..., THE UNIVERSITY OF TEXAS SYSTEM|BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM]] ...3 KB (439 words) - 14:38, 28 April 2025
- ...:{"@type":"Organization","name":"BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM"},"additionalProperty":[{"@type":"PropertyValue","name":"IPC Classification =USE OF HISTONE MODIFIERS TO REPROGRAM EFFECTOR T CELLS= ...3 KB (360 words) - 07:12, 14 May 2025
- =PRODUCTION OF THERAPEUTIC MESENCHYMAL STEM CELL-DERIVED EXOSOMES= ..., THE UNIVERSITY OF TEXAS SYSTEM|BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM]] ...4 KB (644 words) - 05:31, 26 July 2024
- ...um"}],"applicant":{"@type":"Organization","name":"THE TEXAS A&M UNIVERSITY SYSTEM"},"additionalProperty":[{"@type":"PropertyValue","name":"IPC Classification [[:Category:THE TEXAS A&M UNIVERSITY SYSTEM|THE TEXAS A&M UNIVERSITY SYSTEM]] ...3 KB (456 words) - 06:54, 14 May 2025
- ..., The University of Texas System|Board of Regents, The University of Texas System]] [[Category:Board of Regents, The University of Texas System]] ...3 KB (474 words) - 04:52, 18 October 2024
- =COMPOUNDS AND METHODS FOR THERANOSTIC TARGETING OF PARP ACTIVITY= ..., The University of Texas System|Board of Regents, The University of Texas System]] ...4 KB (481 words) - 05:44, 23 August 2024
- ...n and/or developed mucus occlusions are also described, as well as methods of inhibiting mucin secretion in an airway epithelial cell. ...[[:Category:Ying LAI of Chengdu CN|Ying LAI]], [[:Category:Manfred FRICK of Pfaffenhofen a.d. Roth DE|Manfred FRICK]] ...3 KB (471 words) - 09:59, 25 May 2025